Center For Scientific Review; Notice of Closed Meetings, 20082-20083 [2018-09655]
Download as PDF
<![CDATA[
20082
Federal Register / Vol. 83, No. 88 / Monday, May 7, 2018 / Notices
mice, NIAMS inventors have shown that
the interaction between the TNF family
ligand TL1A with its receptor, DR3, is
critical for development of disease in
asthma, inflammatory bowel disease
and multiple sclerosis. They have also
developed anti-TL1A antibodies that
prevent disease in mouse models of
rheumatoid arthritis and inflammatory
bowel disease. This invention describes
anti-human TL1A monoclonal
antibodies that may be useful for the
development of diagnostics and
therapeutics for autoimmune
inflammatory diseases, as well as
methods of treating such diseases by
blocking the interaction between TL1A
and DR3 by the described antibodies.
This specific immunomodulatory effect
provides potential for potent therapy
without inducing global
immunosuppression.
This notice is made in accordance
with 35 U.S.C. 209 and 37 CFR part 404.
The prospective Exclusive Patent
License will be royalty bearing and may
be granted unless within fifteen (15)
days from the date of this published
notice, the NHLBI Office of Technology
Transfer and Development receives
written evidence and argument that
establishes that the grant of the license
would not be consistent with the
requirements of 35 U.S.C. 209 and 37
CFR part 404.
The public may file comments or
objections in response to this Notice.
Comments and objections, other than
those in the form of a license
application, will not be treated
confidentially and may be made
publicly available.
License applications submitted in
response to this Notice will be
presumed to contain business
confidential information and any release
of information in these license
applications will be made only as
required and upon a request under the
Freedom of Information Act, 5 U.S.C.
552.
daltland on DSKBBV9HB2PROD with NOTICES
Dated: April 27, 2018.
Cristina Thalhammer-Reyero,
Senior Licensing and Patenting Manager,
Office of Technology Transfer and
Development, National Heart, Lung, and
Blood Institute.
[FR Doc. 2018–09654 Filed 5–4–18; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
17:38 May 04, 2018
Jkt 244001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Request for Data and Information on
Technologies Used for Identifying
Potential Developmental Toxicants
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
The National Toxicology
Program (NTP) Interagency Center for
the Evaluation of Alternative
Toxicological Methods (NICEATM)
requests available data and information
on approaches and/or technologies
currently used for identifying potential
developmental toxicants. Submitted
information will be used to assess the
state of the science and determine
technical needs for non-animal test
methods used to evaluate the potential
of chemicals to induce adverse effects in
offspring.
DATES: Receipt of information: Deadline
for receipt of information is June 15,
2018.
ADDRESSES: Data and information
should be submitted electronically to
niceatm@niehs.nih.gov.
FOR FURTHER INFORMATION CONTACT: Dr.
Nicole Kleinstreuer, Deputy Director,
NICEATM; email: nicole.kleinstreuer@
nih.gov; telephone: (984) 287–3150.
SUPPLEMENTARY INFORMATION:
Background: NICEATM fosters the
evaluation and promotion of alternative
test methods for regulatory use and
supports efforts to develop, validate,
and implement alternative approaches
for identifying potential developmental
toxicants that replace, reduce, or refine
animal use. Testing a chemical’s
potential to cause developmental
toxicity is required by multiple federal
agencies for regulatory and other
decision contexts, and can use large
numbers of animals.
Request for Information: NICEATM
requests available data and information
on approaches and/or technologies
currently used to identify potential
developmental toxicants. Respondents
should provide information on any
activities relevant to the development or
validation of alternatives to in vivo
developmental toxicity test methods
currently used by federal agencies for
regulatory and other decision contexts.
NICEATM also requests available data
from in vivo developmental studies,
human or animal studies, or accidental
human exposures, using the same
chemicals used to evaluate the
alternative developmental toxicity test
methods.
SUMMARY:
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
Respondents to this request for
information should include their name,
affiliation (if applicable), mailing
address, telephone, email, and
sponsoring organization (if any) with
their communications. The deadline for
receipt of the requested information is
June 15, 2018. Responses to this notice
will be posted at: https://
ntp.niehs.nih.gov/go/dev-nonanimal.
Persons submitting responses will be
identified on the web page by name and
affiliation or sponsoring organization, if
applicable.
Responses to this request are
voluntary. No proprietary, classified,
confidential, or sensitive information
should be included in responses. This
request for information is for planning
purposes only and is not a solicitation
for applications or an obligation on the
part of the U.S. Government to provide
support for any ideas identified in
response to the request. Please note that
the U.S. Government will not pay for
the preparation of any information
submitted or for its use of that
information.
Background Information on
NICEATM: NICEATM conducts data
analyses, workshops, independent
validation studies, and other activities
to assess new, revised, and alternative
test methods and strategies. NICEATM
also provides support for the
Interagency Coordinating Committee on
the Validation of Alternative Methods
(ICCVAM). The ICCVAM Authorization
Act of 2000 (42 U.S.C. 285l–3) provides
authority for ICCVAM and NICEATM
involvement in activities relevant to the
development of alternative test
methods. Information about NICEATM
and ICCVAM can be found at https://
ntp.niehs.nih.gov/go/niceatm and
https://ntp.niehs.nih.gov/go/iccvam.
Dated: April 27, 2018.
Brian R. Berridge,
Associate Director, National Toxicology
Program.
[FR Doc. 2018–09661 Filed 5–4–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center For Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
E:\FR\FM\07MYN1.SGM
07MYN1
Federal Register / Vol. 83, No. 88 / Monday, May 7, 2018 / Notices
daltland on DSKBBV9HB2PROD with NOTICES
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Surgical Sciences,
Biomedical Imaging and Bioengineering
Integrated Review Group, Clinical Molecular
Imaging and Probe Development.
Date: May 31–June 1, 2018.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Crown Plaza Hotel, 11228 Lone
Eagle Dr., Bridgeton, MO 63044.
Contact Person: Donald Scott Wright,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5108,
MSC 7854, Bethesda, MD 20892, (301) 435–
8363, wrightds@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, PAR 15–
326: I/START R03 Grants Program.
Date: June 1, 2018.
Time: 12:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Yvonne Bennett, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5199,
MSC 7846, Bethesda, MD 20892, 301–379–
3793, bennetty@csr.nih.gov.
Name of Committee: Integrative,
Functional and Cognitive Neuroscience
Integrated Review Group, Sensorimotor
Integration Study Section.
Date: June 5, 2018.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Washington Plaza Hotel, 10 Thomas
Circle NW, Washington, DC 20005.
Contact Person: John Bishop, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5182,
MSC 7844, Bethesda, MD 20892, (301) 408–
9664, bishopj@csr.nih.gov.
Name of Committee: Biological Chemistry
and Macromolecular Biophysics Integrated
Review Group, Synthetic and Biological
Chemistry A Study Section.
Date: June 5–6, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Beacon Hotel and Corporate
Quarters, 1615 Rhode Island Avenue NW,
Washington, DC 20036.
Contact Person: Anita Szajek, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4187,
Bethesda, MD 20892, 301–827–6276,
anita.szajek@nih.gov.
VerDate Sep<11>2014
17:38 May 04, 2018
Jkt 244001
Name of Committee: Cardiovascular and
Respiratory Sciences Integrated Review
Group, Lung Cellular, Molecular, and
Immunobiology Study Section.
Date: June 5–6, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Radisson Baltimore Harbor Hotel,
101 West Fayette Street, Baltimore, MD.
Contact Person: George M. Barnas, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2180,
MSC 7818, Bethesda, MD 20892, 301–435–
0696, barnasg@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: May 2, 2018.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–09655 Filed 5–4–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Environmental
Health Sciences; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory
Environmental Health Sciences Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Environmental Health Sciences Council.
Date: June 4–5, 2018.
Closed: June 04, 2018, 8:30 a.m. to 9:15
a.m.
Agenda: To review and evaluate grant
applications.
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
20083
Place: Nat. Inst. of Environmental Health
Sciences, Building 101, Rodbell Auditorium,
111 T. W. Alexander Drive, Research
Triangle Park, NC 27709.
Open: June 04, 2018, 9:30 a.m. to 4:30 p.m.
Agenda: Discussion of Program and Issues.
Place: Nat. Inst. of Environmental Health
Sciences Building 101, Rodbell Auditorium,
111 T. W. Alexander Drive, Research
Triangle Park, NC 27709.
Open: June 05, 2018, 8:30 a.m. to 10:30
a.m.
Agenda: Discussion of Program and Issues.
Place: Nat. Inst. of Environmental Health
Sciences Building 101, Rodbell Auditorium,
111 T. W. Alexander Drive, Research
Triangle Park, NC 27709.
Contact Person: Gwen W. Collman, Ph.D.,
Interim Director, Division of Extramural
Research & Training, National Institutes of
Health, Nat. Inst. of Environmental Health
Sciences, 615 Davis Dr., KEY615/3112,
Research Triangle Park, NC 27709, (919) 541–
4980, collman@niehs.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page:
www.niehs.nih.gov/dert/c-agenda.htm, where
an agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.115, Biometry and Risk
Estimation—Health Risks from
Environmental Exposures; 93.142, NIEHS
Hazardous Waste Worker Health and Safety
Training; 93.143, NIEHS Superfund
Hazardous Substances—Basic Research and
Education; 93.894, Resources and Manpower
Development in the Environmental Health
Sciences; 93.113, Biological Response to
Environmental Health Hazards; 93.114,
Applied Toxicological Research and Testing,
National Institutes of Health, HHS)
Dated: May 2, 2018.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–09657 Filed 5–4–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Government-Owned Inventions;
Availability for Licensing
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
The inventions listed below
are owned by an agency of the U.S.
Government and are available for
licensing in the U.S.
SUMMARY:
E:\FR\FM\07MYN1.SGM
07MYN1
]]>Agencies
[Federal Register Volume 83, Number 88 (Monday, May 7, 2018)]
[Notices]
[Pages 20082-20083]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-09655]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center For Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections
[[Page 20083]]
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant
applications and the discussions could disclose confidential trade
secrets or commercial property such as patentable material, and
personal information concerning individuals associated with the grant
applications, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: Surgical Sciences, Biomedical Imaging and
Bioengineering Integrated Review Group, Clinical Molecular Imaging
and Probe Development.
Date: May 31-June 1, 2018.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Crown Plaza Hotel, 11228 Lone Eagle Dr., Bridgeton, MO
63044.
Contact Person: Donald Scott Wright, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5108, MSC 7854, Bethesda, MD
20892, (301) 435-8363, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel, PAR 15-326: I/START R03 Grants Program.
Date: June 1, 2018.
Time: 12:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Yvonne Bennett, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5199, MSC 7846, Bethesda, MD
20892, 301-379-3793, [email protected].
Name of Committee: Integrative, Functional and Cognitive
Neuroscience Integrated Review Group, Sensorimotor Integration Study
Section.
Date: June 5, 2018.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Washington Plaza Hotel, 10 Thomas Circle NW, Washington,
DC 20005.
Contact Person: John Bishop, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5182, MSC 7844, Bethesda, MD 20892, (301) 408-
9664, [email protected].
Name of Committee: Biological Chemistry and Macromolecular
Biophysics Integrated Review Group, Synthetic and Biological
Chemistry A Study Section.
Date: June 5-6, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Beacon Hotel and Corporate Quarters, 1615 Rhode Island
Avenue NW, Washington, DC 20036.
Contact Person: Anita Szajek, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4187, Bethesda, MD 20892, 301-827-6276,
[email protected].
Name of Committee: Cardiovascular and Respiratory Sciences
Integrated Review Group, Lung Cellular, Molecular, and Immunobiology
Study Section.
Date: June 5-6, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Radisson Baltimore Harbor Hotel, 101 West Fayette Street,
Baltimore, MD.
Contact Person: George M. Barnas, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2180, MSC 7818, Bethesda, MD
20892, 301-435-0696, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: May 2, 2018.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-09655 Filed 5-4-18; 8:45 am]
BILLING CODE 4140-01-P
